首页> 外国专利> VISUALIZATION AND QUANTITIATION OF CELLULAR CYTOTOXICITY USING CELL-PERMEABLE FLUOROGENIC PROTEASE SUBSTRATES AND CASPASE ACTIVITY INDICATOR MARKERS

VISUALIZATION AND QUANTITIATION OF CELLULAR CYTOTOXICITY USING CELL-PERMEABLE FLUOROGENIC PROTEASE SUBSTRATES AND CASPASE ACTIVITY INDICATOR MARKERS

机译:利用细胞渗透性荧光蛋白酶基质和Caspase活性指标标记对细胞毒性进行可视化和定量

摘要

This invention provides a non-radioactive assay to monitor and quantify the target-cell killing activities mediated by cytotoxic T lymphocytes (CTLs). This assay is predicated on the discovery that apoptosis pathway activation and, in particular, caspase activity, provides a measure of cytotoxic effector cell activity. In one embodiment, measurement of CTL-induced caspase activation in target cells is achieved through detection of the specific cleavage of fluorogenic caspase substrates. This assay reliably detects antigen-specific CTL killing of target cells, and provides a more sensitive, more informative and safer alternative to the standard 51Cr-release assay most often used to quantify CTL responses. The assay can be used to study CTL-mediated killing of primary host target cells of different cell lineages, and enables the study of antigen-specific cellular immune responses in real time at the single-cell level. As such, the assay can provide a valuable tool for studies of infectious disease pathogenesis and development of new vaccines and immunotherapies.
机译:本发明提供了一种非放射性测定法,以监测和定量由细胞毒性T淋巴细胞(CTL)介导的靶细胞杀伤活性。该测定基于以下发现:凋亡途径的活化,特别是胱天蛋白酶的活性,提供了细胞毒性效应细胞活性的量度。在一个实施方案中,通过检测荧光半胱天冬酶底物的特异性切割来实现靶细胞中CTL诱导的半胱天冬酶激活的测量。此测定法可可靠地检测靶细胞的抗原特异性CTL杀伤,并为最常用于量化CTL反应的标准51Cr释放测定法提供了更灵敏,信息更丰富,更安全的替代方法。该测定法可用于研究CTL介导的不同细胞谱系的主要宿主靶细胞的杀伤,并能够在单细胞水平上实时研究抗原特异性细胞免疫应答。这样,该测定可以为研究传染病的发病机理以及开发新疫苗和免疫疗法提供有价值的工具。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号